Back
Supernus Pharmaceuticals Vs. Ligand Pharmaceuticals Industry Stock Comparison
Sell
29
SUPN
Supernus Pharmaceuticals
Last Price:
32.11
Seasonality Move:
-9.35%
Buy
60
LGND
Ligand Pharmaceuticals
Last Price:
104.94
Seasonality Move:
1.98%
Sell
29
Supernus Pharmaceuticals (SUPN)
is a Sell
Is Supernus Pharmaceuticals a Buy, Sell or Hold?
- The current Supernus Pharmaceuticals [SUPN] share price is $32.12. The Score for SUPN is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
- SUPN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
60
Ligand Pharmaceuticals (LGND)
is a Buy
Is Ligand Pharmaceuticals a Buy, Sell or Hold?
- The current Ligand Pharmaceuticals [LGND] share price is $105.01. The Score for LGND is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
- LGND is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
SUPN Stock Price Chart
What is Supernus Pharmaceuticals's stock price today?
-
The Supernus Pharmaceuticals share price today is $32.12
The current trend is relatively stagnant and SUPN is experiencing slight buying pressure.
LGND Stock Price Chart
What is Ligand Pharmaceuticals's stock price today?
-
The Ligand Pharmaceuticals share price today is $105.01
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LGND is experiencing slight selling pressure.
SUPN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.21 | Sell |
Relative Strength Index (14 RSI): | 45.86 | Sell |
Chaikin Money Flow: | 72355 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (32.23 - 35.11) | Sell |
Bollinger Bands (100): | (27.01 - 32.71) | Buy |
LGND Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.74 | Buy |
Relative Strength Index (14 RSI): | 55.58 | Buy |
Chaikin Money Flow: | -24402 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (102.37 - 105.49) | Buy |
Bollinger Bands (100): | (81.28 - 103.6) | Buy |
SUPN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 31.72 | Buy |
20-day SMA: | 33.48 | Sell |
50-day SMA: | 31.92 | Buy |
200-day SMA: | 29.77 | Buy |
8-day EMA: | 32.09 | Buy |
20-day EMA: | 32.66 | Sell |
50-day EMA: | 31.9 | Buy |
200-day EMA: | 30.35 | Buy |
LGND Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 103.79 | Buy |
20-day SMA: | 103.94 | Buy |
50-day SMA: | 102.69 | Buy |
200-day SMA: | 82.64 | Buy |
8-day EMA: | 104.03 | Buy |
20-day EMA: | 103.53 | Buy |
50-day EMA: | 100.36 | Buy |
200-day EMA: | 86.22 | Buy |
Supernus Pharmaceuticals Earnings Growth & SUPN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.36 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.02 per share, and a decrease next year of $0.18 per share.
Ligand Pharmaceuticals Earnings Growth & LGND Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.72 per share, an increase next quarter of $0.29 per share, an increase this year of $0.04 per share, and an increase next year of $0.86 per share.
Supernus Pharmaceuticals Technical Analysis
Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Ligand Pharmaceuticals Technical Analysis
Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |